Healthcare is under pressure.
Demographics, a shortage of skilled workers, and rising costs are placing immense strain on hospitals, medical practices, and laboratories. One answer to these systemic challenges is Point-of-Care Testing (POCT) — rapid diagnostics close to the patient.
The new VDGH White Paper 2025 impressively demonstrates how POCT contributes to relief by delivering fast test results directly at the site of care — in emergency settings, long-term care, general practice, or rural regions.
ASKA as a development partner for POCT-based diagnostics
As a specialist in the contract development and manufacturing of immunoassays, antibodies, and recombinant proteins, ASKA Biotech supports diagnostic companies in realizing innovative POCT solutions.
Our services at a glance:
- Development and optimization of qualitative and quantitative immunoassays
- Custom production of antibodies and proteins based on your specifications
- IVDR-compliant development and manufacturing and transfer into market-ready systems
We understand the specific requirements of POCT systems — from stability and ease of use to scalability.
Why POCT matters — according to VDGH
The white paper from the German Diagnostics Industry Association (VDGH) clearly outlines the advantages of POCT in healthcare delivery:
- Diagnosis in minutes for fast treatment decisions
- Relief for practices and emergency departments
- Targeted antibiotic use through differential diagnostics
- Stronger patient engagement and satisfaction
Applications range from cardiac markers (e.g., troponin) to infectious disease diagnostics (CRP, procalcitonin) and diabetes monitoring (HbA1c) — right at the point of care.
Shaping innovation together
ASKA stands for customized diagnostic solutions, short paths, and high flexibility in execution. Together with our partners, we develop POCT-compatible test systems that are clinically relevant, regulatory-compliant, and technically advanced.
You see the need — we deliver the solution. 📩
Let’s get in touch.
Source: VDGH White Paper 2025 – “Point-of-Care Testing: A Groundbreaking Development in Laboratory Diagnostics.”